GlassScriptPhysician profile
Greg N Womack
NPI 1598708646
$2,516.46
in general payments reported to CMS, 2019-2025
15 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.01 · 2020: $106 · 2021: $379 · 2022: $951 · 2023: $540 · 2024: $146 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594 · Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.73 |
| Travel and Lodging | $449.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,432.84 | 2020-2024 | Lumenis Pulse 120h |
| Procept Biorobotics Corporation | $234.77 | 2025 | |
| Astellas Pharma US INC | $202.08 | 2021-2022 | |
| Coloplast Corp | $154.70 | 2019-2023 | Speedicath |
| Teleflex LLC | $152.32 | 2022 | |
| Rochester Medical Corporation | $92.26 | 2021-2022 | |
| Lumenis, INC | $63.10 | 2021 | |
| Valencia Technologies Corporation | $51.31 | 2025 | Ecoin Device Kit |
| Calyxo, INC. | $27.08 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $25.43 | 2019 | |
| Janssen Biotech, INC. | $23.82 | 2025 | Erleada |
| Olympus America INC. | $19.95 | 2025 | Itind System |
| Medtronic USA, INC. | $13.50 | 2020 | |
| Urogen Pharma, INC. | $12.01 | 2021 | |
| Axonics, INC. | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Womack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.